Oma Fertility runs a network of fertility clinics that integrate artificial intelligence and robotics with patient-centered care to offer IVF, IUI, and egg freezing. They own clinics to control the patient experience and costs, and price treatments at ethical, lower-than-average rates. A core product is Oma Sperm InSight™, an FDA-registered AI tool that helps embryologists select the best sperm by analyzing far more cells than manual methods. They include ICSI as a standard part of packages, differentiating through AI-assisted sperm selection and direct care-path control to lower costs and improve success rates, aiming to make fertility care more accessible.
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$37.5M
Headquarters
Santa Barbara, California
Founded
N/A
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
401(k) Company Match
Paid Holidays
Paid Vacation
Paid Sick Leave
Parental Leave
Performance Bonus
Exclusive AI-Assisted Processes Oma Fertility today announces the launch of Oma Sperm InSight™, its patented technology that helps embryologists identify the most promising sperm cell to pair with an egg in IVF.
Oma Fertility partners with Alto Pharmacy to enhance fertility care beyond the clinic.
Oma Fertility has raised $29M through Seed and Series A rounds led by JAZZ Venture Partners, Root Ventures, Mithril Capital, Global Asset Capital, and Free Solo Ventures in addition to a $8.5M debt facility led by Silicon Valley Bank.